Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revolution Medicines, Inc. (RVMD)  
$42.32 0.18 (0.43%) as of 4:30 Tue 2/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 170,000,000
Market Cap: 7.19(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $28.26 - $60.6
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 24.1
Insider 6 Months    : 24.1
Insider 3/6 Months : 48.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,304,347 1,304,347 1,304,347 1,954,347
Total Buy Value $59,999,962 $59,999,962 $59,999,962 $74,145,566
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 3
Total Shares Sold 46,566 313,175 504,180 772,730
Total Sell Value $2,348,134 $15,730,294 $23,274,548 $31,603,889
Total People Sold 5 7 8 9
Total Sell Transactions 8 27 56 93
End Date 2024-11-07 2024-08-06 2024-02-06 2023-02-06

   
Records found: 418
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cislini Jeff General Counsel   •       •      –    2025-01-21 4 AS $40.50 $97,443 D/D (2,406) 39,222 7%     
   Goldsmith Mark A See Remarks   •       •      –    2024-12-18 4 OE $0.49 $15,115 D/D 30,846 355,902     -
   Anders Jack Chief Financial Officer   •       •      –    2024-12-16 4 AS $45.40 $119,639 D/D (2,635) 96,470 -4%     
   Goldsmith Mark A See Remarks   •       •      –    2024-12-16 4 AS $45.40 $531,860 D/D (11,714) 325,056 -4%     
   Cislini Jeff General Counsel   •       •      –    2024-12-16 4 AS $45.40 $72,601 D/D (1,599) 41,628 -4%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-12-16 4 AS $45.40 $211,718 D/D (4,663) 259,745 -4%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-12-16 4 AS $45.40 $196,553 D/D (4,329) 127,991 -4%     
   Schroeder Thilo   –       •      –    2024-12-05 4 B $46.00 $59,999,962 I/I 1,304,347 760,869 0.01 -9%     
   Cislini Jeff General Counsel   •       •      –    2024-11-15 4 AS $55.13 $140,811 D/D (2,554) 43,080 -22%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-11-13 4 AS $58.49 $977,509 D/D (16,666) 264,408 -26%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-11-13 4 OE $4.09 $68,164 D/D 16,666 281,074     -
   Cislini Jeff General Counsel   •       •      –    2024-11-06 4 AS $60.00 $360,000 D/D (6,000) 45,634 -28%     
   Cislini Jeff General Counsel   •       •      –    2024-11-06 4 OE $36.57 $219,420 D/D 6,000 51,634     -
   Goldsmith Mark A See Remarks   •       •      –    2024-11-04 4 OE $0.49 $226,115 D/D 87,500 336,770     -
   Goldsmith Mark A See Remarks   •       •      –    2024-11-04 4 AS $55.56 $2,827,821 D/D (50,900) 300,170 -23%     
   Goldsmith Mark A See Remarks   •       •      –    2024-11-01 4 AS $55.02 $550,239 I/I (10,000) 20,424 -22%     
   Goldsmith Mark A See Remarks   •       •      –    2024-11-01 4 AS $55.02 $500,714 D/D (9,100) 300,170 -22%     
   Goldsmith Mark A See Remarks   •       •      –    2024-11-01 4 OE $4.09 $37,219 D/D 9,100 309,270     -
   Patel Sushil   •       •      –    2024-10-31 4 AS $54.14 $270,715 D/D (5,000) 19,948 -20%     
   Patel Sushil   •       •      –    2024-10-31 4 OE $24.84 $124,200 D/D 5,000 24,948     -
   Kelsey Stephen Michael See Remarks   •       •      –    2024-10-14 4 AS $49.38 $824,804 D/D (16,666) 264,408 -13%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-10-14 4 OE $4.09 $68,164 D/D 16,666 281,074     -
   Horn Margaret A Chief Operating Officer   •       •      –    2024-10-11 4 AS $50.34 $2,517,055 D/D (50,000) 132,320 -15%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-10-11 4 OE $4.09 $204,500 D/D 50,000 182,320     -
   Cislini Jeff General Counsel   •       •      –    2024-10-11 4 AS $50.17 $301,027 D/D (6,000) 45,634 -15%     
  418 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us